These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7754216)

  • 1. Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine.
    Blackbourn DJ; Mackewicz C; Barker E; Levy JA
    Res Immunol; 1994; 145(8-9):653-8; discussion 658-9. PubMed ID: 7754216
    [No Abstract]   [Full Text] [Related]  

  • 2. Noncytolytic CD8 T cell-mediated suppression of HIV replication.
    Greenberg ML; Lacey SF; Chen CH; Bolognesi DP; Weinhold KJ
    Springer Semin Immunopathol; 1997; 18(3):355-69. PubMed ID: 9089954
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of CD8
    McBrien JB; Kumar NA; Silvestri G
    Eur J Immunol; 2018 Jun; 48(6):898-914. PubMed ID: 29427516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
    Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
    AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.
    Mackewicz CE; Yuan J; Tran P; Diaz L; Mack E; Selsted ME; Levy JA
    AIDS; 2003 Sep; 17(14):F23-32. PubMed ID: 14502030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
    Barker E; Mackewicz CE; Levy JA
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11135-9. PubMed ID: 7479952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-1 infection protects against a Tc1-to-Tc2 shift in CD8(+) T cells.
    Gulzar N; Diker B; Balasubramanian S; Jiang JQ; Copeland KF
    Hum Immunol; 2011 Nov; 72(11):995-1000. PubMed ID: 21920400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells.
    Kassu A; Marcus RA; D'Souza MB; Kelly-McKnight EA; Palmer BE
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):1-3. PubMed ID: 20860535
    [No Abstract]   [Full Text] [Related]  

  • 11. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoattractant factors and the control of human immunodeficiency virus replication.
    Baier M; Bannert N; Werner A; Adler HS; Otteken A; Beer B; Norley S; Kurth R
    Pathobiology; 1998; 66(3-4):128-30. PubMed ID: 9693312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines.
    Pahar B; Lackner AA; Veazey RS
    Eur J Immunol; 2006 Mar; 36(3):583-92. PubMed ID: 16506292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
    Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
    J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-Specific CD8
    Reuter MA; Del Rio Estrada PM; Buggert M; Petrovas C; Ferrando-Martinez S; Nguyen S; Sada Japp A; Ablanedo-Terrazas Y; Rivero-Arrieta A; Kuri-Cervantes L; Gunzelman HM; Gostick E; Price DA; Koup RA; Naji A; Canaday DH; Reyes-Terán G; Betts MR
    Cell Rep; 2017 Dec; 21(12):3458-3470. PubMed ID: 29262326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
    Appay V; Nixon DF; Donahoe SM; Gillespie GM; Dong T; King A; Ogg GS; Spiegel HM; Conlon C; Spina CA; Havlir DV; Richman DD; Waters A; Easterbrook P; McMichael AJ; Rowland-Jones SL
    J Exp Med; 2000 Jul; 192(1):63-75. PubMed ID: 10880527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J; Barrett L; Bowmer MI; Howley C; Grant M
    AIDS; 2004 Mar; 18(4):597-604. PubMed ID: 15090764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells.
    Poli G; Kinter AL; Vicenzi E; Fauci AS
    Res Immunol; 1994; 145(8-9):578-82. PubMed ID: 7754203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.